Pfizer to buy 9.9% stake in HK-listed CStone Pharma for $200m

Pfizer to buy 9.9% stake in HK-listed CStone Pharma for $200m

A company logo is seen through branches at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter